Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel heterogeneous copper catalyst enables high yield chiral synthesis for pharmaceutical intermediates supply chain optimization and significant cost reduction capabilities for global buyers.
Novel copper-catalyzed substitution route for efficient ligand production enabling high-performance ruthenium dehydrogenation catalysts for pharmaceutical applications.
Patent CN113912562A reveals a green, catalyst-free route for oxazepine derivatives, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN103406148A details high-activity NHC-Pd catalysts for aminocarbonylation. Discover cost-effective synthesis and scalable supply solutions for pharmaceutical intermediates.
Patent CN1293942C reveals a robust Ni(0) catalyst system using metallic nickel powder for efficient adiponitrile synthesis, offering significant cost and stability advantages.
Patent CN106187897A reveals catalyst-free synthesis. High yield, simplified purification. Reliable pharmaceutical intermediates supplier for cost reduction.
Patent CN110396072B details a cost-effective dual-catalyst route for (S)-3-hydroxytetrahydrofuran, offering high optical purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN109369715A reveals high-yield synthesis route. Offers significant cost reduction and supply chain reliability for complex ligand manufacturing processes globally.
Patent CN108164501A enables mild carbonyl sulfide conversion for high-purity intermediates. Delivers substantial cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Novel heterogeneous catalyst method reduces Pd usage and enables recycling for sustainable furan derivative production.
Patent CN102351907A reveals a nickel-mediated transmetallation route for diverse metal-NHC catalysts, offering cost-effective manufacturing for pharmaceutical and fine chemical applications.
Patent CN114044771B reveals a mild Rh-catalyzed tandem reaction for furan-2(5H)-one skeletons, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN117720467A reveals a novel 4-step route for chiral catalysts, offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN115745822A enables green visible light synthesis of N-formyl amides using copper catalysis, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel tertiary amine-thiourea catalyst enables high-yield asymmetric conjugate addition for scalable API intermediate production with superior enantioselectivity.
Novel Rh-catalyzed C-H activation method for high-purity axial chiral intermediates with superior enantioselectivity and scalable process efficiency.
Novel aluminum catalyst enables anti-Markovnikov hydroamination with high yield. Reduces cost and improves supply chain reliability for amine synthesis.
Discover a novel selenium-catalyzed method for propargyl alpha-amino boronate synthesis. Offers mild conditions, broad substrate scope, and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN112679336A reveals a green heterogeneous Pd@POL catalytic route for phenylpropionic acids, offering reduced heavy metal residues and enhanced supply chain reliability for pharmaceutical intermediates.
Novel metal-free synthesis of functionalized allenones using N-heterocyclic carbene catalysts. Offers high atom economy and scalability for pharmaceutical intermediates.